KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-25

  1. 1,077 Posts.
    lightbulb Created with Sketch. 92
    Yet with two market sensitive news releases our way, that company still easily outperformed Novogen on the ASX today - in terms of both value and share price movement.

    Maybe tomorrow may prove different.

    But thus far we've learned more about you when you bag NOX than anything else.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.